3.53
Abcellera Biologics Inc (ABCL) 最新ニュース
AbCellera Secures Global Settlement and Patent License Deal - TipRanks
AbCellera Biologics Inc Settles Patent Litigation with Bruker - TradingView — Track All Markets
Why AbCellera Biologics Inc. stock could rally in 2025Portfolio Update Summary & Low Risk Growth Stock Ideas - Улправда
AbCellera Biologics (NASDAQ:ABCL) Trading 6.7% HigherHere's What Happened - MarketBeat
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
Bruker (BRKR) Agrees to $36M Settlement with AbCellera (ABCL) - GuruFocus
AbCellera (ABCL) Secures $36M Settlement and License Deal with B - GuruFocus
AbCellera settles patent dispute with Bruker for $36 million upfront By Investing.com - Investing.com Australia
AbCellera settles patent litigation with Bruker over microfluidic device tech - Seeking Alpha
Abcellera and Bruker reach global settlement of patent litigation - marketscreener.com
AbCellera Biologics Says Bruker to Pay $36 Million Upfront in Patent Litigation Settlement - marketscreener.com
AbCellera and Bruker Reach Global Settlement of Patent Litigation - Business Wire
Can AbCellera Biologics Inc. stock hit analyst price targetsWeekly Trend Report & Free Safe Capital Growth Stock Tips - Улправда
Energy Moves: How interest rate cuts could boost AbCellera Biologics Inc. stockTrade Risk Summary & Accurate Buy Signal Alerts - moha.gov.vn
AbCellera Appoints Dr. Stephen Quake to Board - MSN
Norges Bank Makes New $2.16 Million Investment in AbCellera Biologics Inc. $ABCL - MarketBeat
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - BioSpace
AbCellera Biologics’ Earnings Call: Key Insights - MSN
AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results - Finviz
Published on: 2025-12-04 02:33:18 - Newser
ABCL: Advancing a differentiated internal pipeline with strong capital support and end-to-end integration - TradingView
Can AbCellera Biologics Inc. (8QQ) stock resist broad market declines2025 Momentum Check & Safe Capital Preservation Plans - Newser
What dividend safety rating applies to AbCellera Biologics Inc. (8QQ) stock2025 Trade Ideas & Fast Gain Stock Tips - Newser
What makes AbCellera Biologics Inc. (8QQ) stock appealing to growth investorsPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
9 Best Up and Coming Canadian Stocks to Buy - Insider Monkey
AbCellera Biologics Inc. (ABCL) Approved to Begin ABCL575 Trial for Atopic Dermatitis - MSN
Will AbCellera Biologics Inc. stock benefit from sector rotationJuly 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
Published on: 2025-11-29 10:31:39 - earlytimes.in
AbCellera Biologics to change independent auditor after 2025 annual report By Investing.com - Investing.com Nigeria
AbCellera Biologics to change independent auditor after 2025 annual report - Investing.com
Insider Spends US$178k Buying More Shares In AbCellera Biologics - Yahoo Finance
AbCellera biologics director Montalbano buys $178k in shares By Investing.com - Investing.com Nigeria
AbCellera biologics director Montalbano buys $178k in shares - Investing.com
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss - MSN
13 Best Canadian Penny Stocks to Buy Right Now - Insider Monkey
AbCellera Biologics Inc. (ABCL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How AbCellera Biologics Inc. (8QQ) stock correlates with oil marketsJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Is AbCellera Biologics Inc. (8QQ) stock safe for risk averse investors2025 Fundamental Recap & AI Driven Stock Reports - newser.com
How AbCellera Biologics Inc. (8QQ) stock compares with market leadersJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
大文字化:
|
ボリューム (24 時間):